abstract |
The present disclosure provides biomarkers and methods of their use in determining the presence or absence of cancer. In preferred embodiments, biomarkers and methods of their use determine the presence or absence of ovarian cancer, a type of ovarian cancer and/or a stage of ovarian cancer in a sample from an individual. |